198 related articles for article (PubMed ID: 8390719)
1. What lessons can be learned from animal model studies in viral heart disease?
Gauntt C; Higdon A; Bowers D; Maull E; Wood J; Crawley R
Scand J Infect Dis Suppl; 1993; 88():49-65. PubMed ID: 8390719
[TBL] [Abstract][Full Text] [Related]
2. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
[TBL] [Abstract][Full Text] [Related]
3. Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis.
Gauntt CJ; Arizpe HM; Higdon AL; Wood HJ; Bowers DF; Rozek MM; Crawley R
J Immunol; 1995 Mar; 154(6):2983-95. PubMed ID: 7533190
[TBL] [Abstract][Full Text] [Related]
4. Persistent expression of cytokines in the chronic stage of CVB3-induced myocarditis in NMRI mice.
Glück B; Schmidtke M; Merkle I; Stelzner A; Gemsa D
J Mol Cell Cardiol; 2001 Sep; 33(9):1615-26. PubMed ID: 11549341
[TBL] [Abstract][Full Text] [Related]
5. The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains.
Klingel K; Kandolf R
Scand J Infect Dis Suppl; 1993; 88():79-85. PubMed ID: 8390720
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
7. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
8. T lymphocyte responses in CVB3-induced murine myocarditis.
Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
[TBL] [Abstract][Full Text] [Related]
9. Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis.
Neumann DA; Rose NR; Ansari AA; Herskowitz A
J Immunol; 1994 Jan; 152(1):343-50. PubMed ID: 8254202
[TBL] [Abstract][Full Text] [Related]
10. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice.
Huber SA
Lab Invest; 1997 May; 76(5):691-701. PubMed ID: 9166288
[TBL] [Abstract][Full Text] [Related]
11. [Virus demonstration and pathologic changes in different phases of coxsackievirus B myocarditis in mice].
Rabausch-Starz I; Neu N; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1990; 74():398-403. PubMed ID: 1708625
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profiles in heart, spleen, and thymus during the acute stage of experimental coxsackievirus B3-induced chronic myocarditis.
Schmidtke M; Glück B; Merkle I; Hofmann P; Stelzner A; Gemsa D
J Med Virol; 2000 Aug; 61(4):518-26. PubMed ID: 10897072
[TBL] [Abstract][Full Text] [Related]
13. Coxsackievirus B3-induced myocarditis in MHC class II-deficient mice.
Leipner C; Borchers M; Merkle I; Stelzner A
J Hum Virol; 1999; 2(2):102-14. PubMed ID: 10225212
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus B3-induced chronic myocarditis in outbred NMRI mice.
Merkle I; Tonew M; Glück B; Schmidtke M; Egerer R; Stelzner A
J Hum Virol; 1999; 2(6):369-79. PubMed ID: 10774554
[TBL] [Abstract][Full Text] [Related]
15. Animal models for autoimmune myocarditis and autoimmune thyroiditis.
Ciháková D; Sharma RB; Fairweather D; Afanasyeva M; Rose NR
Methods Mol Med; 2004; 102():175-93. PubMed ID: 15286386
[TBL] [Abstract][Full Text] [Related]
16. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
[TBL] [Abstract][Full Text] [Related]
18. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
19. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
[TBL] [Abstract][Full Text] [Related]
20. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
